Fischer Medical Ventures Outlines Integrated AI Healthcare Ecosystem Strategy
Fischer Medical Ventures Ltd 路 Investor Presentation 路 17 Sept 2026, 9:31 pm
Fischer Medical Ventures Outlines Integrated AI Healthcare Ecosystem Strategy Fischer Medical Ventures Limited submitted its revised investor presentation for the analyst call held on 7th Sep'26, detailing its platform combining AI-enabled medical imaging, population-scale screening, and hospital digitization. The ecosystem integrates Time Medical's proprietary imaging hardware (MRI, CT, X-Ray, mammography) and FlynnCare's diagnostic AI platforms (MIDAS, LIVE Dx, Clinics 2.0, ATLAS). Key portfolio offerings span helium-free and open MRI systems, portable AI X-rays, and portfolio companies NanoMedic, Obelab, Nervotec, and Nanyang Biologics. Geographies include India, the US, MENA, and SEA.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 路 15 Nov 2026
- Outcome of Board Meeting held on 14th Nov 2026 for approval of Q2 financials 路 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. 路 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... 路 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company 路 27 Oct 2026
